The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency.
about
Cyclic nucleotide-gated channel subunit glycosylation regulates matrix metalloproteinase-dependent changes in channel gatingMolecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation.Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infectionPhotocross-linking of nascent chains to the STT3 subunit of the oligosaccharyltransferase complexHyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine designCrystal structure of a recombinant alphaEC domain from human fibrinogen-420The oligosaccharyltransferase complex from Saccharomyces cerevisiae. Isolation of the OST6 gene, its synthetic interaction with OST3, and analysis of the native complex.Protein stability: a crystallographer's perspectiveFunctional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1N-Glycosylation of Human R-Spondin 1 Is Required for Efficient Secretion and Stability but Not for Its Heparin Binding AbilityPlaying hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.Protein structure as a means to triage proposed PTM sites.The central domain of bovine submaxillary mucin consists of over 50 tandem repeats of 329 amino acids. Chromosomal localization of the BSM1 gene and relations to ovine and porcine counterparts.Systematic Analysis of proteoglycan modification sites in Caenorhabditis elegans by scanning mutagenesis.Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility.Identification of triadin 1 as the predominant triadin isoform expressed in mammalian myocardium.Identification of minimum carbohydrate moiety in N-glycosylation sites of brain endothelial cell glycoprotein 96 for interaction with Escherichia coli K1 outer membrane protein AN-glycosylation efficiency is determined by the distance to the C-terminus and the amino acid preceding an Asn-Ser-Thr sequonRecurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infectionsIntegrating bioinformatics tools to handle glycosylationIdentification of CCR2-binding features in Cytl1 by a CCL2-like chemokine model.Glycosylation of {beta}2 subunits regulates GABAA receptor biogenesis and channel gatingEpitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies.Definition of the bacterial N-glycosylation site consensus sequence.Mass spectrometry approach and ELISA reveal the effect of codon optimization on N-linked glycosylation of HIV-1 gp120Site-specific N-glycosylation analysis of human factor XI: Identification of a noncanonical NXC glycosite.Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.Functionalized silk assembled from a recombinant spider silk fusion protein (Z-4RepCT) produced in the methylotrophic yeast Pichia pastoris.Unraveling the mechanism of protein N-glycosylation.A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum GlycoproteinsRegulated motion of glycoproteins revealed by direct visualization of a single cargo in the endoplasmic reticulumLarge-Scale Measurement of Absolute Protein Glycosylation Stoichiometry.N-linked glycosylation is required for transferrin-induced stabilization of transferrin receptor 2, but not for transferrin binding or trafficking to the cell surface.N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies.Identification of the forkhead transcriptional factor 2 (FOXL2) gene mutations in four Chinese families with blepharophimosis syndrome.The development of modified human Hsp70 (HSPA1A) and its production in the milk of transgenic mice.Missense mutations near the N-glycosylation site of the A2 domain lead to various intracellular trafficking defects in coagulation factor VIII.Folding and assembly of type X collagen mutants that cause metaphyseal chondrodysplasia-type schmid. Evidence for co-assembly of the mutant and wild-type chains and binding to molecular chaperones.Molecular mechanisms underlying HBsAg negativity in occult HBV infection.N-glycoprotein macroheterogeneity: biological implications and proteomic characterization.
P2860
Q24338934-23AAE15E-6C17-40EA-A9F6-B79BA8DE59B6Q24529180-B8144F97-52F8-45B3-9DEC-3E1FA935A19EQ24538985-6F27EA02-85C5-454D-B4DD-42CB9660D7C7Q24652203-3A650CCA-2400-4BA5-9CDF-58D75F35E58EQ24679395-E12E957B-BA03-48D0-A650-98B044641464Q27764895-FB6F03F0-2569-42F1-8869-82968641DCE6Q27937029-065A4124-A89D-429A-8BB4-D02751B54EF2Q28068775-5BCC2F10-26F0-45D4-89B3-4E7D48A2D00CQ28359804-9531DD8D-85C0-4053-928E-89F56D40E797Q28828423-098DFDD9-C842-4A3F-8894-7CA245B92967Q30360290-EFCF391B-7500-4C8F-A160-295D11B92533Q30423942-5E049F2B-274C-47BC-9FA7-EBE4A14A0FA1Q30856884-D03FCEFA-286B-4C9F-A0C7-45CB2D742790Q33279266-CC9EFA64-4529-4F0B-A32C-F8EBAB0E09B8Q33323199-7B31E4D9-67CE-4B65-A218-59041088834EQ33875009-E763FE3C-D924-4725-B348-49163EF9E050Q34010122-F138DF88-1E47-4AB4-8784-C21EF9623D7CQ34024744-33A1A56F-0913-4505-8BD8-A5532100952CQ34042642-1EF23AD9-1DEB-46C5-86C6-14E2618B31E5Q34118984-98C1323F-87A9-4FA1-BEE6-18980A371B3FQ34164671-AFF47712-66D8-40A0-8BE7-C123182CE0EEQ34181328-BDF53BE9-51CE-4275-BF8E-B9F4A238729EQ34542092-85ED3D1F-71D3-43AC-930F-48E0E76CA7E1Q34590466-AE7B470E-71CE-4B25-A5B4-D431009B9081Q34669472-832CA07D-2A1A-4E0F-8DEC-6D502FF9C803Q35219258-8062B6EE-FA76-4044-A4C9-954AE3E1FC4AQ35666098-AA2B0DB6-1FF4-4D48-BDAD-193135E3F408Q35905302-1A013277-55F3-44B5-B958-68C5FB1687E8Q35980135-04403BF9-7A7B-4F11-8035-B12542B25D17Q36348802-657EDDAA-43AE-4501-9DE4-D2DE8035AF2BQ36404949-BA713A4F-98DD-4F71-82EA-8C857C4B15AEQ36508954-65DEE1DF-1A7A-4890-BD1E-31AA6C2FA0F6Q36851726-3E611ACC-8116-48BD-B359-A7068C72B368Q37010852-6BDC6A57-C2E2-4C9F-8CDE-2278BCA22C34Q37326941-D6174B09-0F4B-4978-9D63-6EAA9E3A1508Q37372965-1A59EF50-4D8F-4A26-AC02-BEE0EE7F0544Q37715039-83F91B42-33A4-4356-8BC8-437A0E1F50E4Q38327412-B9DC7FB9-F876-487C-A0F3-E913BAEB52A6Q38536404-35F003F2-C85E-4883-90CA-0571AAF25D6EQ38659790-D81F3BBF-C531-4876-9AA7-3352C685A92F
P2860
The amino acid following an asn-X-Ser/Thr sequon is an important determinant of N-linked core glycosylation efficiency.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The amino acid following an as ...... core glycosylation efficiency.
@ast
The amino acid following an as ...... core glycosylation efficiency.
@en
The amino acid following an as ...... core glycosylation efficiency.
@nl
type
label
The amino acid following an as ...... core glycosylation efficiency.
@ast
The amino acid following an as ...... core glycosylation efficiency.
@en
The amino acid following an as ...... core glycosylation efficiency.
@nl
prefLabel
The amino acid following an as ...... core glycosylation efficiency.
@ast
The amino acid following an as ...... core glycosylation efficiency.
@en
The amino acid following an as ...... core glycosylation efficiency.
@nl
P2093
P356
P1433
P1476
The amino acid following an as ...... core glycosylation efficiency.
@en
P2093
Mellquist JL
Shakin-Eshleman SH
Spitalnik SL
P304
P356
10.1021/BI972217K
P407
P577
1998-05-01T00:00:00Z